Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Zhang S, Shen J, Li D, Cheng Y. · 2021
Read Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing. by Zhang S, Shen J, Li D, Cheng Y. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7738854.txt.
Introduction
Zhang and co-authors review how to deliver gene-editing tools into cells as a prebuilt complex. CRISPR/Cas9 editing can fix faulty genes, but getting the machinery into target cells is a bottleneck. Delivering the Cas9 protein bound to its guide RNA has a key edge: the edit is brief, and off-target cuts fall.
The review sorts delivery routes into physical methods and synthetic carriers. It explains how each route gets the complex across the cell membrane. Star cases include carriers that respond to cues or home to a tissue. The authors weigh the weak points of current systems. They sketch design rules for the next wave of carriers.
Catalog record
| CREATOR | Zhang S, Shen J, Li D, Cheng Y. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 150 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing By Song Zhang, Jiangtao Shen, Dali Li, Yiyun Cheng Published in: Theranostics DOI: 10.7150/thno.47007 ABSTRACT Abstract CRISPR/Cas9 genome editing has gained rapidly increasing attentions in recent years, however, the translation of this biotechnology into therapy has been hindered by efficient delivery of CRISPR/Cas9 materials into target cells. Direct delivery of CRISPR/Cas9 system as a ribonucleoprotein (RNP) complex consisting of Cas9 protein and single guide RNA (sgRNA) has emerged as a powerful and widespread method for genome editing due to its advantages of transient genome editing and reduced off-target effects. In this review, we summarized the current Cas9 RNP delivery systems including physical approaches and synthetic carriers. The mechanisms and beneficial roles of these strategies in intracellular Cas9 RNP delivery were reviewed. Examples in the development of stimuli-responsive and targeted carriers for RNP delivery are highlighted. Finally, the challenges of current Cas9 RNP delivery systems and perspectives in rational design of next generation materials for this promising field will be discussed. Keywords: genome editing, CRISPR, RNP, polymers, nanoparticles INTRODUCTION The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system as a revolutionary genome editing technology offers a powerful tool for scientific research and has great potential in the treatment of various diseases 1, 2. To date, more than 3000 human genes have been identified to be associated with genetic disorders and over 500 genes are related with susceptibility to complex diseases or infections 3. Therefore, genome editing tools like the CRISPR/Cas system have gained great attentions over the past decade for the well promise of treating genetic disorders 4-8. The native CRISPR/Cas system is an adaptive immune system in bacteria and archaea that protects themselves from invasive nucleic acids. Nakata and co-workers first reported a set of highly homologous sequence in the 3' end of E. coli iap gene in 1987 9. In the following years, studies have shown that similar repeating sequences exist in a variety of bacteria and archaea, and then the acronym CRISPR was first proposed by Jansen et al. in 2002 10. In 2005, Mojica et al. found that virus cannot infect cells possessing interval sequence with homology to the virus, so they speculated that the CRISPR and associated proteins might participate in the immune function against transmissible genetic elements 11, 12. Following these initial studies, a rapid increase of investigations have revealed more details of the characteristics and mechanisms on CRISPR system 13. In 2012, Doudna, Charpentier and colleagues first reported that the CRISPR-associate protein 9 can be adapted to genome editing with a customized CRISPR RNA (crRNA) together with a common transactivating CRISPR RNA (tracrRNA) or an artificial single guide RNA (sgRNA) which was a chimeric crRNA-tracrRNA hybrid 14. The CRISPR/Cas9 system has been further proven to be effective for genome editing in eukaryotic cells for the first time in 2013 15, 16. Subsequently, a flurry of papers proved the efficacy of CRISPR/Cas9 on genome editing in various species 17-24. CRISPR/Cas systems can be divided into two classes by the difference of Cas proteins content. The class 1 system needs multiple Cas proteins to form the CRISPR-associated complex for antiviral defense (CASCADE), while the class 2 system only relies on a single Cas protein with multiple domains. The class 1 system contains type I, III and IV and the class 2 system contains type II and type V. Each type of CRISPR/Cas system possesses a distinctive composition of expression, interference, and adaptation modules. They are distinguishable by the presence of unique signature proteins: Cas3 for type I, Cas9 for type II, Cas10 for type III, Csf1 for type IV and Cas12a (Cpf1) for Type V 25. Among these different types of CRISPR/Cas systems, the type II system based on CRISPR/Cas9 from streptococcus pyogenes is the most widely studied and applied due to its simplicity, versatility, efficiency and specificity 26-29. Two critical components of the CRISPR/Cas9 system are Cas9 nuclease and sgRNA (Figure 1A) 14. The CRISPR/Cas9 gene-targeting is directed by the sgRNA formed by hybridization of a tracrRNA and a crRNA 16. The targeting crRNA is composed by a ~20-nt sequence (the protospacer) complementary to the target DNA with the sequence requirement of a protospacer adjacent motif (PAM) (5'-NGG for the mostly used SpCas9) 30. The tracrRNA hybridizes to the crRNA and binds directly to the Cas9 nuclease to form a ribonucleoprotein (RNP) complex 31. The CRISPR/Cas9 gene-editing function is directed by the Cas9 nuclease. There are two lobes of the Cas9 nuclease: a nuclease (NUC) lobe and a target recognition (REC) lobe. The RuvC, HNH and PAM-interacting domains comprise the NUC lobe. The HNH domain cleaves the target DNA strand complementary to crRNA while the RuvC domain cleaves the other strand, finally resulting in a double-stranded break (DSB) at the target site (Figure 1B) 14, 32. DSBs are mainly repaired by nonhomologous end joining (NHEJ) or homology directed repair (HDR) pathway (Figure 1C) 18, 33-35. NHEJ is error-prone and typically leads to indels (insertion and/or deletion of nucleotides) at the site of the break which would knockout a gene when the reading frame was shifted (Figure 1C) 36, 37. For the HDR pathway, a template DNA containing a sequence homologous to the DSBs is required to repair or precisely modify the genome of proliferating cells 38. Thus, utilizing the mechanism of HDR can repair disease-causing mutations or knock in customized sequences at DSBs loci to induce desired genotype (Figure 1C). NHEJ, the principal and most rapid pathway for DSB repair, is active throughout the cell cycle, while HDR is active during the S or G2 phase of cell cycle 33, 39. It is worth mentioning that the efficiency of HDR-mediated gene replacement or knock-in is much lower than gene knock-out 40, 41. NHEJ can also be applied to mediate genome integration in the presence of a donor vector that contains the desired transgene flanked by a CRISPR target site (Figure 1C) 42-44. Besides the classical NHEJ pathway, there are other alternative error-prone repair mechanisms of end joining, such as microhomology-mediated end joining (MMEJ) (Figure 1C). MMEJ repairs DSBs by annealing microhomologies, which are 2 to 20-bp stretches of overlapping bases flanking the DSB 45. MMEJ is highly mutagenic with a high frequency of missense and indels in the franking sequences 46. At the same time, MMEJ can also be utilized to mediate precise integration of exogenous DNA as another powerful complementary strategy to the HDR-based knock-in strategy 47. In the presence of a donor template harboring microhomology arms (5-40 bp) flanking the genomic target locus, MMEJ could be used to mediate precise insertion of exogenous DNA (Figure 1C) 48-51. In addition, homology-mediated end joining (HMEJ)-based strategy with long homology arms (~800 bp) was reported to achieve precise gene integration with greater knock-in efficiency than MMEJ-based strategy (Figure 1C) 52-54. [Figure: Schematic illustration of the structure and molecular mechanism of the CRISPR/Cas9 system. A. structure of Cas9 protein and sgRNA. B. Formation of DSB via CRISPR/Cas9 system. C. The repair mechanisms of DSBs.] A very necessary prerequisite for CRISPR/Cas9 complex to function is the efficient delivery of the complex into nucleus of target cells. The CRISPR/Cas9 complex could be delivered in the forms of